SG11202005157RA - Anisotropic nanoparticle compositions and methods - Google Patents

Anisotropic nanoparticle compositions and methods

Info

Publication number
SG11202005157RA
SG11202005157RA SG11202005157RA SG11202005157RA SG11202005157RA SG 11202005157R A SG11202005157R A SG 11202005157RA SG 11202005157R A SG11202005157R A SG 11202005157RA SG 11202005157R A SG11202005157R A SG 11202005157RA SG 11202005157R A SG11202005157R A SG 11202005157RA
Authority
SG
Singapore
Prior art keywords
methods
nanoparticle compositions
anisotropic nanoparticle
anisotropic
compositions
Prior art date
Application number
SG11202005157RA
Inventor
Peter Robert Butzloff
Original Assignee
Buckyol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buckyol Ltd filed Critical Buckyol Ltd
Publication of SG11202005157RA publication Critical patent/SG11202005157RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/48Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by oxidation reactions with formation of hydroxy groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/44Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed ring system having more than three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2604/00Fullerenes, e.g. C60 buckminsterfullerene or C70

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202005157RA 2017-12-14 2018-04-11 Anisotropic nanoparticle compositions and methods SG11202005157RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762598466P 2017-12-14 2017-12-14
PCT/US2018/027177 WO2019117986A1 (en) 2017-12-14 2018-04-11 Anisotropic nanoparticle compositions and methods

Publications (1)

Publication Number Publication Date
SG11202005157RA true SG11202005157RA (en) 2020-06-29

Family

ID=66819469

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005157RA SG11202005157RA (en) 2017-12-14 2018-04-11 Anisotropic nanoparticle compositions and methods

Country Status (12)

Country Link
US (1) US20210379103A1 (en)
EP (1) EP3724158A4 (en)
JP (1) JP2021506766A (en)
KR (1) KR20200084040A (en)
CN (1) CN111971264A (en)
AU (1) AU2018383334B2 (en)
CA (1) CA3083357C (en)
MY (1) MY194469A (en)
PH (1) PH12020550884A1 (en)
RU (1) RU2020119061A (en)
SG (1) SG11202005157RA (en)
WO (1) WO2019117986A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110342499B (en) * 2019-07-26 2022-05-27 广西科学院 Method for preparing fullerene-like carbon spheres by micro-oxygen ablation of biomass high-temperature carbonization tail end
WO2022035429A1 (en) * 2020-08-12 2022-02-17 Butzloff Peter Robert Nootropic fullerenes and use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648523A (en) * 1995-10-26 1997-07-15 Chiang Long Y Fullerene derivatives as free-radical scavengers
JP2003530926A (en) * 2000-04-14 2003-10-21 ヴァージニア テック インテレクチュアル プロパティーズ インコーポレイテッド Self-assembled thin-film coatings to enhance material biocompatibility
EP1595936B1 (en) * 2003-01-27 2011-10-19 Vitamin C60 Bioresearch Corporation Composition for external use
JP2004231595A (en) * 2003-01-31 2004-08-19 Mitsubishi Chemicals Corp Nerve cell protector containing hydroxyfullerene
US7329429B2 (en) * 2003-09-25 2008-02-12 Chimel Mark J Bars and confectioneries containing cocoa solids having a high cocoa polyphenol content and sterol/stanol esters and processes for their preparation
RU2283273C2 (en) * 2004-08-27 2006-09-10 Арсений Борисович Березин Fullerene solution preparation method
US8058483B2 (en) * 2007-02-02 2011-11-15 Dvb Global Composition of matter containing harmonized hydroxyl modified fullerene substance
FR2949044B1 (en) * 2009-08-12 2021-05-07 Expanscience Lab COMPOSITION INCLUDING A FRACTION OF THE UNSAPONIFIABLE
US9085463B2 (en) * 2011-01-17 2015-07-21 Marelle, Llc Water-soluble functionalized fullerenes
JP2012184199A (en) * 2011-03-07 2012-09-27 Nara Institute Of Science & Technology Water-soluble photosensitizing material using fullerene derivative
EE201200005A (en) * 2012-03-27 2013-12-16 Humal Priit Apparatus for diagnosing or controlling bee varroasis, method and software for parasite detection
DE102013006265A1 (en) * 2013-04-11 2014-10-16 Richard Rossa Apparatus and method for controlling varroa mites in the hive
US20170165334A1 (en) * 2015-12-11 2017-06-15 Tianxin Wang Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
US9884955B2 (en) * 2015-04-22 2018-02-06 Totai Co., Ltd. Hydroxylated-fullerene-containing solution, resin molding and resin composition each using the same, and method for producing each of the resin molding and the resin composition
CN107846870B (en) * 2015-06-14 2021-04-20 托比影响力创新有限公司 Device for killing insects in beehive and method for controlling beehive to kill insects
KR102429873B1 (en) * 2015-08-31 2022-08-05 삼성전자주식회사 Anisotropic conductive material, electronic device including anisotropic conductive material and method of manufacturing electronic device
US10064395B2 (en) * 2015-09-18 2018-09-04 Mario Chapa Beehive monitoring system

Also Published As

Publication number Publication date
CA3083357C (en) 2022-06-21
PH12020550884A1 (en) 2021-04-12
RU2020119061A3 (en) 2021-12-09
JP2021506766A (en) 2021-02-22
MY194469A (en) 2022-11-30
US20210379103A1 (en) 2021-12-09
KR20200084040A (en) 2020-07-09
CN111971264A (en) 2020-11-20
EP3724158A1 (en) 2020-10-21
RU2020119061A (en) 2021-12-09
CA3083357A1 (en) 2019-06-20
WO2019117986A1 (en) 2019-06-20
AU2018383334A1 (en) 2020-06-11
EP3724158A4 (en) 2022-01-26
AU2018383334B2 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
HK1254733A1 (en) In situ cross-linkable polysaccharide compositions and uses thereof
GB2546350B (en) Compositions and methods
ZA201805805B (en) Formulations and methods
HK1251183A1 (en) Bioconjugates and uses thereof
SI3580561T1 (en) Hla-based methods and compositions and uses thereof
GB201718876D0 (en) Antithrombin-heparin compositions and methods
GB201807325D0 (en) Compositions and methods
IL288342A (en) Compositions and methods for nanoparticle lyophile forms
GB201706355D0 (en) Methods compositions and uses relating thereto
GB201706356D0 (en) Methods compositions and uses relating thereto
IL274176A (en) Compositions and methods for enhancing visual function
GB201706352D0 (en) Methods compositions and uses relating thereto
ZA202004533B (en) Skin-brightening compositions and methods
GB201705626D0 (en) Compositions and methods
SG11202005157RA (en) Anisotropic nanoparticle compositions and methods
GB201713268D0 (en) Glycosaminoglycan-coated metallic nanoparticles and uses thereof
ZA201807665B (en) Methods and compositions
GB201715820D0 (en) Compositions and methods
EP3563861C0 (en) Ginseng-derived nanoparticle and preparation and application thereof
GB201715785D0 (en) Methods compositions and uses relating thereto
GB201512996D0 (en) Compositions and methods
IL253174A0 (en) Nanoparticles and methods for preparation thereof
GB201703975D0 (en) Composition and methods
GB201514413D0 (en) Compositions and methods
ZA201807782B (en) Methods and compositions